Anixa Biosciences and Moffitt Cancer Center Advance Ovarian Cancer CAR-T Clinical Trial to Highest Dose Level to Date

Go back to Anixa Biosciences and Moffitt Cancer Center Advance Ovarian Cancer CAR-T Clinical Trial to Highest Dose Level to Date
(NASDAQ: ANIX) Delayed: 2.84 +0.08 (2.90%)
Previous Close $2.76    52 Week High
Open $2.79    52 Week Low
Day High $2.88    P/E N/A 
Day Low $2.76    EPS
Volume 209,828